GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

NUTX · Dec 31, 2025

Nutex Health Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001628280-26-015168General Corporate
Debt relative to revenue0thOwn-history percentile · N=10
Evidence method

Level · gp.fundamentals.debt_to_revenue

4.86% · OPTIONAL · VALID

Capex intensityRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

0.29% · OPTIONAL · NOT_ENOUGH_HISTORY

Operating cash generation90thOwn-history percentile · N=10
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

28.35% · OPTIONAL · VALID

Revenue growthRAWCurrent state valid · history insufficient
Evidence method

Yoy · gp.fundamentals.revenue

82.36% · CORE · NOT_ENOUGH_HISTORY

Inventory pressure0thOwn-history percentile · N=10
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

0.33% · OPTIONAL · VALID

Gross margin70thOwn-history percentile · N=10
Evidence method

Level · gp.fundamentals.gross_margin

50.76% · CORE · VALID

Operating margin80thOwn-history percentile · N=10
Evidence method

Level · gp.fundamentals.operating_margin

31.49% · CORE · VALID

SBC intensityRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

12.31% · OPTIONAL · NOT_ENOUGH_HISTORY

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History15 statesHistory building
Jun 30, 20230/6 normalizedLevel 3Sep 30, 20230/5 normalizedLevel 3Dec 31, 20230/5 normalizedLevel 3Mar 31, 20240/5 normalizedLevel 3Jun 30, 20240/6 normalizedLevel 3Sep 30, 20240/6 normalizedLevel 3Dec 31, 20240/6 normalizedLevel 3Mar 31, 20250/6 normalizedLevel 3Dec 31, 20240/8 normalizedAmended as filedMar 31, 20250/8 normalizedAmended as filedJun 30, 20255/8 normalizedLevel 3Sep 30, 20255/8 normalizedLevel 3Dec 31, 20255/8 normalizedLevel 3Mar 31, 20265/7 normalizedLevel 3Jun 30, 20266/7 normalizedLevel 3
Period transition

What moved in the state?

Balance Sheet Leverage Decreased
Previous
16.27%
Current
4.86%
Delta
-11.42%
Capex Intensity Increased
Previous
0.11%
Current
0.29%
Delta
0.18%
Cash Generation Decreased
Previous
37.16%
Current
28.35%
Delta
-8.81%
Growth Decreased
Previous
239.87%
Current
82.36%
Delta
-157.51%
Inventory Pressure Decreased
Previous
1.18%
Current
0.33%
Delta
-0.85%
Margin Decreased
Previous
57.83%
Current
50.76%
Delta
-7.07%
Profitability Decreased
Previous
48.68%
Current
31.49%
Delta
-17.19%
Sbc Intensity Increased
Previous
8.54%
Current
12.31%
Delta
3.77%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Transitioned To · NUTX Fundamental State →Has State · Nutex Health Inc. →Transitioned To · NUTX Fundamental State →Transitioned To · NUTX BALANCE_SHEET_LEVERAGE_DECREASED →Transitioned To · NUTX CAPEX_INTENSITY_INCREASED →Transitioned To · NUTX CASH_GENERATION_DECREASED →Transitioned To · NUTX GROWTH_DECREASED →Transitioned To · NUTX INVENTORY_PRESSURE_DECREASED →Transitioned To · NUTX MARGIN_DECREASED →Transitioned To · NUTX PROFITABILITY_DECREASED →Transitioned To · NUTX SBC_INTENSITY_INCREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.